Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome.

Linyuan WangPeter F RambauLinda E KelemenMichael S AnglesioSamuel LeungAline TalhoukMartin Koebel

Published in: Histopathology (2019)

Nuclear β-catenin and CDX2 expression individually or in combination are validated prognostic markers for ovarian EC. However, their full potential to stratify low risk patients at adjuvant threshold awaits further multimarker study.

Keyphrases

poor prognosis
epithelial mesenchymal transition
cell proliferation
early stage
binding protein
long non coding rna
risk assessment
climate change